Sangamo Therapeutics
SGMO
#10608
Rank
C$42.8 M
Marketcap
C$0.10
Share price
0.00%
Change (1 day)
-87.33%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total debt

Total debt on the balance sheet as of March 2026 : C$26.99 Million

According to Sangamo Therapeutics 's latest financial reports the company's total debt is C$26.99 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Sangamo Therapeutics - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$36.69 M-16.34%
2024-12-31C$43.86 M-13.21%
2023-12-31C$50.53 M-13.6%
2022-12-31C$58.49 M-4.54%
2021-12-31C$61.27 M14.19%
2020-12-31C$53.66 M-7.47%
2019-12-31C$57.99 M53.76%
2018-12-31C$37.71 M21.27%
2017-12-31C$31.1 M486.66%
2016-12-31C$5.3 M
2015-12-31N/A
2001-12-31C$0.45 M
1999-12-31C$0.43 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
C$68.46 B 253,551.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$80.01 B 296,320.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$11.66 B 43,119.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
C$27.12 B 100,396.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$36.64 B 135,664.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$75.26 B 278,743.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$1.76 B 6,456.02%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$5.86 B 21,637.02%๐Ÿ‡บ๐Ÿ‡ธ USA